GlassScriptPhysician profile
Shairoz Sultan Patel
NPI 1396214755
$4,250.75
in general payments reported to CMS, 2019-2025
37 companies · $992 in 2025
The $992 reported for 2025 was more than what 83% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,014 · 2022: $806 · 2023: $773 · 2024: $666 · 2025: $992.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,326 · Education: $105.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,325.57 |
| Education | $105.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $716.48 | 2021-2025 | |
| Lilly USA, LLC | $424.65 | 2021-2025 | Mounjaro, Jardiance, Zepbound |
| Novo Nordisk INC | $371.12 | 2021-2025 | Wegovy, Ozempic, Rybelsus |
| Inspire Medical Systems, INC. | $356.53 | 2023-2025 | Inspire |
| Pfizer INC. | $334.89 | 2023-2025 | |
| Astellas Pharma US INC | $260.91 | 2024-2025 | Veozah |
| Glaxosmithkline, LLC. | $243.46 | 2021-2024 | Shingrix, Arexvy, Trelegy Ellipta |
| Abbott Laboratories | $218.53 | 2023-2025 | Freestyle Libre 3, Freestyle Libre 2, Eterna |
| Amgen INC. | $204.59 | 2021-2025 | Otezla, Repatha, Repatha |
| Teva Pharmaceuticals USA, INC. | $129.05 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $123.02 | 2021-2023 | Trintellix |
| Biohaven Pharmaceutical Holding Company LTD. | $90.83 | 2022 | |
| Exact Sciences Corporation | $69.61 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Shield Therapeutics INC | $67.74 | 2025 | |
| Dexcom, INC. | $63.62 | 2022-2025 | Dexcom G6 Transmitter |
Show all 37 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shairoz Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.